UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - INSTIL BIO INC ownership

INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 1 filers reported holding INSTIL BIO INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 100.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of INSTIL BIO INC
ValueSharesWeighting
Q2 2022$933,093,000
-58.6%
201,968
-3.8%
0.00%
-100.0%
Q1 2022$2,256,318,000
-41.9%
209,890
-7.5%
0.00%0.0%
Q4 2021$3,881,935,000
-6.2%
226,881
-2.0%
0.00%
-50.0%
Q3 2021$4,139,546,000
-10.0%
231,583
-2.7%
0.00%0.0%
Q2 2021$4,597,367,000237,9590.00%
Other shareholders
INSTIL BIO INC shareholders Q2 2024
NameSharesValueWeighting ↓
CPMG Inc 8,478,790$163,810,00027.08%
VR Adviser, LLC 6,865,076$132,633,00016.09%
Vivo Capital, LLC 12,486,787$241,245,00010.44%
Fairmount Funds Management LLC 673,905$13,020,0005.35%
Samsara BioCapital, LLC 2,145,395$41,449,0005.12%
Logos Global Management LP 1,696,850$32,783,0002.76%
RA Capital Management 4,870,793$94,104,0001.51%
Nicholas Investment Partners, LP 852,819$16,476,0001.03%
HighVista Strategies LLC 41,436$801,0000.57%
HHLR ADVISORS, LTD. 2,385,457$46,087,0000.47%
View complete list of INSTIL BIO INC shareholders